Tech Company Financing Transactions
Biothera Funding Round
Biothera closed a investment round on 6/30/2010. Investors included private investors.
Transaction Overview
Company Name
Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3388 Mike Collins Dr. A
Eagan, MN 55121
USA
Eagan, MN 55121
USA
Phone
Website
Email Address
Not Recorded
Overview
Biothera Pharmaceuticals is dedicated to unlocking the promise of cancer immunotherapy. Our phase 2 drug Imprime PGG is a Pathogen Associated Molecular Patterning (PAMP) molecule that works like an immunological ignition switch to coordinate innate and adaptive immune responses.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Mueller
Chief Scientific Officer
Jeremy Graff
VP - Bus. Development
Steven Karel
VP - Finance
Tamas Mir
Browse more venture capital transactions:
Prev: 6/30/2010: Oxane Materials venture capital transaction
Next: 6/30/2010: Chain Reaction Ecommerce venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs